Dosimetric validation of the Theragenics AgX-100® I-125 seed for ROPES eye plaque brachytherapy

With the discontinued distribution of the I-125 Oncura Onco seed (model 6711), the Theragenics AgX100® I-125 seeds were considered as a suitable alternative for eye plaque brachytherapy as their physical properties matched the requirements for use with the ROPES eye plaques. The purpose of this study aims at validating the dosimetry of the AgX-100 loaded ROPES plaques (11 mm diameter, 15 mm diameter with flange, 15 mm diameter with notch, 18 mm diameter) and assess the differences with the discontinued I-125 6711 model. To independently verify the plaque dosimetry, the brachytherapy module of RADCALC® version 6.2.3.6 was commissioned for the new AgX-100 I-125 seed using the published AAPM TG43 data from the literature. Experimental dosimetry verification was performed using EBT3 Gafchromic™ film and TLD-100 micro-cubes in a specially designed Solid Water® phantom. Both RADCALC® and film confirmed the dosimetry calculated by Plaque Simulator (PS) version 6.4.6 The dose calculated by PS agrees with RADCALC® to within 2% for depths of 1–15 mm for the 4 available ROPES plaques. The dosimetric measurements agreed with the calculations of PS for clinically relevant depths (4 mm to 6 mm) within the evaluated uncertainties of 4.7% and 7.2% for EBT3 film and TLDs respectively. The AgX-100 I-125 seed was a suitable replacement for the 6711 I-125 seed. Due to the introduction of the stainless-steel backscatter factor in PS v6.4.6, the department has decided to report both the homogenous dose and heterogeneity corrected dose for each eye plaque patient.

[1]  L. Dewerd,et al.  Development of a phantom to validate high-dose-rate brachytherapy treatment planning systems with heterogeneous algorithms. , 2015, Medical physics.

[2]  J. Poder,et al.  I-125 ROPES eye plaque dosimetry: validation of a commercial 3D ophthalmic brachytherapy treatment planning system and independent dose calculation software with GafChromic® EBT3 films. , 2013, Medical physics.

[3]  G. Ibbott,et al.  Thermoluminescence dosimetry measurements of brachytherapy sources in liquid water. , 2008, Medical physics.

[4]  Zuofeng Li,et al.  Monte Carlo and experimental dosimetry of an I125 brachytherapy seed. , 2006, Medical physics.

[5]  Ravinder Nath,et al.  Supplement 2 for the 2004 update of the AAPM Task Group No. 43 Report: Joint recommendations by the AAPM and GEC-ESTRO. , 2017, Medical physics.

[6]  G. A. Carlsson,et al.  Response of LiF:Mg,Ti thermoluminescent dosimeters at photon energies relevant to the dosimetry of brachytherapy (<1 MeV). , 2011, Medical physics.

[7]  L A DeWerd,et al.  LiF:Mg,Ti TLD response as a function of photon energy for moderately filtered x-ray spectra in the range of 20-250 kVp relative to 60Co. , 2008, Medical physics.

[8]  Larry A DeWerd,et al.  A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO. , 2011, Medical physics.

[9]  G. Ibbott,et al.  Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the (125)I I-Seed AgX100 source model. , 2012, Brachytherapy.

[10]  O. A. García-Garduño,et al.  Evaluation of the uncertainty in an EBT3 film dosimetry system utilizing net optical density , 2016, Journal of applied clinical medical physics.

[11]  J F Williamson,et al.  Comparison of measured and calculated dose rates in water near I-125 and Ir-192 seeds. , 1991, Medical physics.

[12]  G. Luxton,et al.  Comparison of radiation dosimetry in water and in solid phantom materials for I-125 and Pd-103 brachytherapy sources: EGS4 Monte Carlo study. , 1994, Medical physics.

[13]  J. Galvin,et al.  Radiochromic film dosimetry: recommendations of AAPM Radiation Therapy Committee Task Group 55. American Association of Physicists in Medicine. , 1998, Medical physics.

[14]  K. Hogstrom,et al.  Dose-response curve of EBT, EBT2, and EBT3 radiochromic films to synchrotron-produced monochromatic x-ray beams. , 2012, Medical physics.

[15]  Ravinder Nath,et al.  Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS. , 2012, Medical physics.

[16]  M. Sadeghi,et al.  ROPES eye plaque brachytherapy dosimetry for two models of 103Pd seeds , 2011, Australasian Physical & Engineering Sciences in Medicine.

[17]  K. Shortt,et al.  The response of lif thermoluminescence dosemeters to photon beams in the energy range from 30 kV x rays to 60Co gamma rays. , 2003, Radiation protection dosimetry.